Table 1.

Silencing RNAs of CoViD-19.

S. No	siRNA	Target	Sequence	Inhibition efficacy	GC%
1	virsi2257	ORF5, M	AACCUAGUAAUAGGUUUCCUA	91	33
2	virsi1323	N	GAACAAACCCAAGGAAAUU	83	37
3	virsi1304	N	GAACAAACCCAAGGAAAUU	94	37
4	virsi1374	N	UCAAGGAACAACAUUGCCAAA	51	38
5	virsi1382	N	AAUAAUACUGCGUCUUGGUUC	80	38
6	virsi2267	ORF9a, N-Protein	AAAUUGGCUACUACCGAAGAG	91	43
7	virsi1330	Pol	UAUGACUAUGUCAUAUUCA	80	26
8	virsi2233	ORF1b, NSP-13	AAGGUGACUAUGGUGAUGCUG	92	48
9	virsi1351	S	AUCUGUUCUCUAAACGAAC	93.4	35
10	virsi2241	orf1, spike	AACCUUACAGAGUUGUAGUAC	91	32
11	VIRSI2237	ORF2, Spike	AAGCUCCUAAUUACACUCAAC	91.2	35
12	VIRSI1584	3CL Protease	GGAUGAAGAAGAUGGCCAU	91	40
13	VIRSI1696	E	CGGAGACAUCAGACAACUA	90
14	VIRSI1611	NS1	GGAUGAAGAAGAUGGCCAU	88	40
15	SiCoV2-1	Orf 1a	GUUUAUACCUUCCCAGGUA	93.72	42.8
16	SiCoV2-2	Orf 1a	GCACUAGUACUGAUGUCGUAU	93.36	52.38
17	SiCoV2-3	Orf 1a	GGACAACAGGGCAACCUUACA	92.98	47.62
18	SiCoV2-4	N	GACAACAGGGCAACCUUACAA	92.85	42.8
19	SiCoV2-5	S	AGGCUGUUGCUAAUGGUGAUU	92.85	47.62
20	SiCoV2-6	E	GGCUGUUGCUAAUGGUGAUUC	92.74	42.86
21	SiCoV2-7	Orf1a	AGAUGGCUGAUCAAGCUAUGA	92.42	38.1
22	SiCoV2-8	Orf 1b	AGUUGGAUAAUGAUGCACUCA	92.28	38.1
23	SiCoV2-9	Nsp5	GUUGGAUAAUGAUGCACUCAA	92.1	33.33
24	SiCoV2-10	E	GAACAUAAUACCUCUUACAAC	91.63	38.1
25	SiCoV2-11	S	GUUGUCAUACCAGACUAUAAC	91.62	42.86
26	SiCoV2-12	M	GUUGACAUACUAGGACCUCUU	91.31	38.1
27	SiCoV2-13	M	GGUUCUGUUGCUUAUGAAAGU	91.41	47.62
28	SiCoV2-14	Orf1a	GUGCUCAUGGAUGGCUCUAUU	90.69	41.86
29	SiCoV2-15	Orf 1b	GAAGGUUCUGUUAGAGUGGUA	90.63	52.38
30	SiCoV2-16	Orf 1b	GGCACGGCACUUGUGAAAGAU	90.28	33.33
31	SiCoV2-17	Orf 1ab	GAUGGGUACUUAACAAUGAUU	90.2	33.33
32	SiCoV2-18	Orf 1b	GACAUAUCAGCAUCUAUAGUA	90.04	38.1
33	SiCoV2-19	N	GGUAUUGUAGCUAUCGUAGUA	90.3	37
34	SiCoV2-20	M	GAGCAACAAGAGUCGAAUGUA	90	42.86